Literature DB >> 26374836

Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.

Lily Mushahar1, Lim Wei Mei2, Wan Shaariah Yusuf2, Sudhaharan Sivathasan2, Norilah Kamaruddin2, Nor Juliana Mohd Idzham2.   

Abstract

UNLABELLED: ♦
OBJECTIVE: Peritoneal dialysis (PD)-related infection is a common cause of catheter loss and the main reason for PD drop-out. Exit-site infection (ESI) is a pathway to developing tunnel infection and peritonitis, hence rigorous exit-site care has always been emphasized in PD therapy. The aim of this study was to evaluate the effect of exit-site dressing vs non-dressing on the rate of PD-related infection. ♦
METHODS: A prospective randomized controlled study was conducted in prevalent PD patients at the Hospital Tuanku Jaafar Seremban, Negeri Sembilan, Malaysia, from April 2011 until April 2013. All patients were required to perform daily washing of the exit site with antibacterial soap during a shower. In the dressing group (n = 54), patients were required to clean their exit site using povidone-iodine after drying, followed by topical mupirocin antibiotic application to the exit site. The exit site was then covered with a sterile gauze dressing and the catheter immobilized with tape. In the non-dressing group (n = 54), patients were not required to do any further dressing after drying. They were only required to apply mupirocin cream to the exit site and then left the exit site uncovered. The catheter was immobilized with tape. The primary outcome was ESI. The secondary outcomes were evidence of tunnel infection or peritonitis. ♦
RESULTS: A total of 97 patients completed the study. There were a total of 12 ESI episodes: 4 episodes in 4 patients in the dressing group vs 8 episodes in 4 patients in the non-dressing group. This corresponds to 1 episode per 241.3 patient-months vs 1 episode per 111.1 patient-months in the dressing and non-dressing groups respectively. Median time to first ESI episode was shorter in the non-dressing than in the dressing group, but not significant (p = 0.25). The incidence of gram-positive ESI in both groups was similar. There were no gram-negative ESI in the non-dressing group compared with 2 in the dressing group. The peritonitis rate was 1 per 37.1 patient-month in the dressing group and 1 per 44.4 patient-months in the non-dressing group. Median time to first peritonitis episode was significantly shorter in the dressing group compared to non-dressing (p = 0.03). There was no impact of dressing disruptions in the occurrence of major PD catheter-related infection. ♦
CONCLUSION: Use of a non-dressing technique with only prophylactic topical mupirocin cream application is effective in preventing PD-related infection. The non-dressing technique is more cost-effective and convenient for PD patients, with fewer disposables.
Copyright © 2016 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Dressings; exit-site infection; peritonitis; tunnel infection

Mesh:

Substances:

Year:  2015        PMID: 26374836      PMCID: PMC4803357          DOI: 10.3747/pdi.2014.00195

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  27 in total

1.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

2.  Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial.

Authors:  M A Luzar; C B Brown; D Balf; L Hill; B Issad; B Monnier; J Moulart; J C Sabatier; J P Wauquier; F Peluso
Journal:  Perit Dial Int       Date:  1990       Impact factor: 1.756

3.  Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis.

Authors:  R Bayston; M Andrews; K Rigg; A Shelton
Journal:  Perit Dial Int       Date:  1999 Nov-Dec       Impact factor: 1.756

4.  Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis.

Authors:  Miguel Pérez-Fontán; Miguel Rosales; Ana Rodríguez-Carmona; Teresa García Falcón; Francisco Valdés
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

5.  A study of the efficacy of dressings in preventing infections of continuous ambulatory peritoneal dialysis catheter exit sites.

Authors:  M Naylor; B Roe
Journal:  J Clin Nurs       Date:  1997-01       Impact factor: 3.036

6.  Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis.

Authors:  Miguel Pérez Fontan; Ana Rodríguez-Carmona; Rafael García-Naveiro; Miguel Rosales; Pedro Villaverde; Francisco Valdés
Journal:  Perit Dial Int       Date:  2005 May-Jun       Impact factor: 1.756

7.  Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.

Authors:  Judith Bernardini; Filitsa Bender; Tracey Florio; James Sloand; Linda Palmmontalbano; Linda Fried; Beth Piraino
Journal:  J Am Soc Nephrol       Date:  2004-12-29       Impact factor: 10.121

Review 8.  Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials.

Authors:  Giovanni F M Strippoli; Allison Tong; David Johnson; Francesco P Schena; Jonathan C Craig
Journal:  Am J Kidney Dis       Date:  2004-10       Impact factor: 8.860

9.  Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey.

Authors:  Gertrude Kopriva-Altfahrt; Paul König; Michael Mündle; Friedrich Prischl; Johannes M Roob; Martin Wiesholzer; Andreas Vychytil; Kalus Arneitz; Andrea Karner; Rene Artes; Erich Wolf; Martin Auinger; Andrzej Pawlak; Johannes Fraberger; Sabine Hofbauer; Georg Galvan; Hermann Salmhofer; Birgit Pichler; Melanie Wazel; Manfred Gruber; Anni Thonhofer; Alfred Hager; Sabine Malajner; Susanne Heiss; Thomas Braunsteiner; Monika Zweiffler; Paul König; Michael Rudnicki; Richard Kogler; Dietmar Kohlhauser; Tatjana Wiesinger; Gertrude Kopriva-Altfahrt; Elizabeth Moser; Peter Kotanko; Herbert Loibner; Helga Nitz; Hans Joachim Miska; René Wenzel; Monika Wölfer; Michael Mündle; Heimo Breuss; Bertram Hölzl; Friedrich Prischi; Bernhard Schmekal; Eva-Maria Riener; Johannes M Roob; Waltraud Wonisch; Rudolf Vikydal; Andreas Vychytil; Barbara Frank; Clemens Wieser; Martin Wiesholzer; Karin Pokorny
Journal:  Perit Dial Int       Date:  2009 May-Jun       Impact factor: 1.756

10.  A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).

Authors:  Sarbjit V Jassal; Charmaine E Lok
Journal:  Perit Dial Int       Date:  2008 Jan-Feb       Impact factor: 1.756

View more
  4 in total

1.  Catheter-related infections in peritoneal dialysis: comparison of a single center results and the literature data.

Authors:  Sabrina Milan Manani; Grazia Maria Virzì; Anna Giuliani; Carlo Crepaldi; Claudio Ronco
Journal:  J Nephrol       Date:  2019-04-06       Impact factor: 3.902

2.  Self-reported impact of the exit-site on usual activities and its association with clinical outcomes in patients undergoing peritoneal dialysis.

Authors:  Zhikai Yang; Jiayu Hao; Nanzha Abi; Yuhui Zhang; Ying Xu; Tiantian Ma; Jie Dong
Journal:  J Nephrol       Date:  2022-08-20       Impact factor: 4.393

3.  Histone deacetylase 6 inhibition counteracts the epithelial-mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis.

Authors:  Liuqing Xu; Na Liu; Hongwei Gu; Hongrui Wang; Yingfeng Shi; Xiaoyan Ma; Shuchen Ma; Jun Ni; Min Tao; Andong Qiu; Shougang Zhuang
Journal:  Oncotarget       Date:  2017-09-18

4.  Comparative efficacy of 13 antimicrobial dressings and different securement devices in reducing catheter-related bloodstream infections: A Bayesian network meta-analysis.

Authors:  Fang-Ping Dang; Hui-Ju Li; Jin-Hui Tian
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.